About Breye Therapeutics
Breye Therapeutics develops oral medicines for retinal diseases, with a focus on diabetic retinopathy and age-related macular degeneration.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Hørsholm, Denmark
Year Founded
2022
Team Size
11-50
Tracked Since
Oct 4, 2026
Web & Domain Identity
Official Website
breye.com
Domain Registered Date
May 4, 2005
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $76,650,000 · Series-A
Backed by Mission BioCapital, Novo Holdings
- Capital Raise
Raised $4,120,000 · Seed
Backed by Novo Holdings, Sound Bioventures
- Milestone
Company founded
Hørsholm, Denmark
- Milestone
Website domain registered
breye.com
Investors & Backers
Catalyze Capital
Export and Investment Fund
Innovestor
Mission BioCapital
Modi Ventures
Novo Holdings
Pappas Capital
Sound Bioventures
The Ljungstrom Family Office
Vaekstfonden
Funding History
Series-A equity
· Sep 29, 2026
Round backers: Mission BioCapital, Novo Holdings, Catalyze Capital, Export and Investment Fund, Innovestor, Modi Ventures, Pappas Capital, Sound Bioventures, The Ljungstrom Family Office
$76,650,000 european-biotechnology.com
Seed equity
· Nov 11, 2022
Round backers: Novo Holdings, Sound Bioventures
$4,120,000 finsmes.com
Founders & Leadership
Ulrik Mouritzen
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026